News
BLFS
27.39
+4.90%
1.28
BioLife Solutions Strengthens Board with Tony J. Hunt Appointment
TipRanks · 1d ago
Benchmark Co. Sticks to Their Buy Rating for BioLife Solutions (BLFS)
TipRanks · 1d ago
BioLife Solutions Price Target Maintained With a $30.00/Share by Benchmark
Dow Jones · 2d ago
Benchmark Reiterates Buy on BioLife Solns, Maintains $30 Price Target
Benzinga · 2d ago
Azenta upgraded to Overweight, named new ‘Best Idea’ at Stephens
TipRanks · 3d ago
BIOLIFE SOLUTIONS APPOINTS TONY J. HUNT TO ITS BOARD OF DIRECTORS
Reuters · 5d ago
Press Release: BioLife Solutions Appoints Tony J. Hunt to its Board of Directors
Dow Jones · 5d ago
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), BioLife Solutions (BLFS) and Delcath Systems (DCTH)
TipRanks · 5d ago
Weekly Report: what happened at BLFS last week (1209-1213)?
Weekly Report · 5d ago
BIOLIFE SOLUTIONS INC <BLFS.O>: JEFFERIES RAISES TARGET PRICE TO $31 FROM $30
Reuters · 6d ago
BioLife Solutions Is Maintained at Overweight by Keybanc
Dow Jones · 12/13 15:09
Keybanc Maintains Overweight on BioLife Solns, Raises Price Target to $33
Benzinga · 12/13 14:58
BioLife Solutions price target raised to $33 from $30 at KeyBanc
TipRanks · 12/13 11:25
BioLife Solutions (BLFS) Receives a Buy from KeyBanc
TipRanks · 12/13 08:32
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Sinopharm Group Co (OtherSHTDF)
TipRanks · 12/12 07:51
Weekly Report: what happened at BLFS last week (1202-1206)?
Weekly Report · 12/09 10:02
How The Pieces Add Up: IJR Headed For $137
NASDAQ · 12/06 12:35
Weekly Report: what happened at BLFS last week (1125-1129)?
Weekly Report · 12/02 10:02
BLUECHIIP LTD - SIGNS LICENCE, DEVELOPMENT AND SUPPLY AGREEMENT WITH BIOLIFE SOLUTIONS
Reuters · 12/02 05:02
Weekly Report: what happened at BLFS last week (1118-1122)?
Weekly Report · 11/25 09:58
More
Webull provides a variety of real-time BLFS stock news. You can receive the latest news about Biolife Solutions Inc through multiple platforms. This information may help you make smarter investment decisions.
About BLFS
BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.